Postpoliomyelitis Syndrome Clinical Trial
Official title:
A Phase III, Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Therapeutic Effect of the Association of L-carnitine and Piracetam as an Adjuvant Therapy in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome
This protocol aims to assess of L-carnitine and piracetam to relieve weakness, muscle fatigue and muscle pain in patients with Postpoliomyelitis Syndrome.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05663008 -
Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis
|
||
Completed |
NCT00001185 -
Study of "Post-Polio Syndrome"
|
N/A | |
Recruiting |
NCT06320444 -
Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease
|
||
Completed |
NCT01271530 -
Arm Cycling to Improve Fitness in Polio Survivors
|
N/A | |
Completed |
NCT00004553 -
Electromyography to Diagnose Neuromuscular Disorders
|
N/A | |
Terminated |
NCT00067496 -
Modafinil to Treat Fatigue in Post-Polio Syndrome
|
Phase 3 |